Boehringer Ingelheim joins Oxford BioMedica, UK
Cystic Fibrosis Gene Therapy Consortium, and Imperial Innovations to form a partnership for developing a new gene therapy to treat cystic fibrosis. / read more /
Researchers from the Department of Chemistry and Warwick Medical School developed a way to synthesize polymers to accelerate antimicrobial activity screening. / read more /
Westminster Pharmaceuticals, LLC is voluntarily
recalling levothyroxine and liothyronine after FDA issues import alert affecting the active ingredient. / read more /
The new drug, Onpattro (patisiran), by Alnylam Pharmaceuticals, is in a new class of drugs called small interfering ribonucleic acid (siRNA)
treatment. / read more /
The agency issued a warning letter to Canadian API manufacturer, Les Produits Chimiques B.G.R, citing cGMP violations at its API facility in Pointe-Claire, Quebec. / read more /
Development costs and time to market continue to put pressure on the biopharma industry, driving the need for innovation in methods and technologies. / read more /
Jean-Yves Balfin, product manager at Korsch AG, speaks to Pharmaceutical Technology Europe about the ins and outs of multilayer tableting. / read more /
A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions. / read more /
Cleanroom Documentation Systems
VAI has solved the challenges surrounding particulate and fiber contamination in controlled areas by developing CleanPrint 10, the Core2Print, and Core2Write and has addressed cleanroom traceability via our Core2Scan System. / Read more/
This ebook covers novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs, including single-use systems, facilities and equipment, contamination issues, and process analytics.
